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According to the structure-to-function paradigm proteins fold into a 3D structure for exerting their
functions. Intrinsically destructured proteins with important biological functions have been identi-
ﬁed and studied, but they assume a structure when interacting in the cell with their partners. There
are instead bactericidal proteins, endowed also with other diverse activities (glycoside hydrolases,
RNases, a defensin), which are lost when the proteins are denatured or inactivated, whereas the bac-
tericidal activity is surprisingly conserved.
The hypothesis is advanced that these proteins are not bactericidal per se, but because they store
in their amino acid sequences peptide segments that display bactericidal activity when cut out as
free peptides from the proteins. These bactericidal proteins would thus be merely containers of bac-
tericidal peptides.
 2011 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.The ‘‘Anﬁnsen’s dogma’’ has been read for decades to assert that
an unfolded polypeptide chain can spontaneously fold into its na-
tive, three-dimensional structure [1]. The apparent corollary of the
‘‘dogma’’ has been the structure-to-function paradigm, stating that
folding into a well deﬁned structure is a crucial requirement for a
protein to exist as a biomolecule that exerts a deﬁned biological
function.
Undoubtedly, to perform its biological function, a protein must
interact with a speciﬁc partner. In the encounter with its partner,
the protein offers an interacting surface, deﬁned by a precisely
poised three-dimensional conformation.
Later on, proteins devoid of structure, in parts or completely,
but displaying important biological functions, have been identiﬁed
and studied. They exist as ‘‘intrinsically destructured proteins’’
(IDP), and have been studied in several laboratories (see for
reviews [2–5]). It has been determined that about 30% of all
eukaryotic proteins are IDP, with key roles in basic cellular
functions, such as transcription, translation, signal transduction,
and in the cell cycle. Their lack of structure has even led to cast
doubts on the validity of the structure-to-function paradigm [4].
However, these studies have also revealed that IDP do assume a
folded, deﬁnite structure when they interact with their physiolog-
ical partner, such as another protein, or a DNA site, as the cell phys-
iology requires. In other words, IDP have been found to acquire a
structure when they perform their function. Conversely, it is rea-
sonable to consider that as long as a destructured protein is
destructured, it may not have a function.on behalf of the Federation of EuroIn conclusion, unstructured proteins contain the potential for
structure(s), and are necessarily ready, when required, to organize
into a structure(s). Thus, the structure–function paradigm may not
need to be re-evaluated.
But there are other proteins which can exert a biological activity
in the absence of a structure. They have no relation with IDP,
involved with key roles in various important cell functions, and
are instead characterized by a bactericidal activity, which they pos-
sess together with an independent enzymatic activity, as they are
glycoside hydrolases, RNases, a defensin.
When these proteins are unfolded through full denaturation, or
their enzymatic active site is strongly perturbed or completely
obliterated, they still conserve their bactericidal activity. It should
be noted that a great variety of bacteria was employed in these
studies.
The earliest data on proteins with bactericidal activity also after
denaturation have been obtained when studying historical lyso-
zyme. Hen egg white lysozyme was found to be still active as a bac-
tericidal agent after denaturation with dithiothreitol [6], and T4
lysozyme was found to conserve its bactericidal activity when
denatured through heat treatment [7].
Similar results were obtained when the enzymatic, muramidase
activity of hen egg white lysozyme was inactivated by replacing
key catalytic residues through site-directed mutagenesis [8]. In
all these cases the muramidase activity of lysozyme was lost upon
denaturation or inactivation, but the bactericidal activity was not
lost.
Analogous results have been reported for various RNases, all
phylogenetically related as members of the vertebrate, secreted
RNase superfamily [9]. Human RNase 3 [10] and chicken RNasepean Biochemical Societies.
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their RNase activity was abolished. Upon heat denaturation, the
bactericidal activity of rat eosinophil-associated RNases Ear-1
and -2 has been found to increase, whereas their RNase activity
was severely impaired [12]. It has been found that the RNase activ-
ity of human RNase 7 is lost when its essential catalytic residues
are replaced, but its bactericidal activity is maintained, provided
that clusters of Lys residues are preserved in the inactivated en-
zyme [13]. Furthermore, all ﬁsh RNases isolated and described so
far: ﬁve RNases from zebraﬁsh [14], two from the Atlantic salmon
[15], cease to be active as RNases when fully denatured, but pre-
serve their bactericidal activity [14,15].
Recently [16], human b-defensin 1 (hBD-1), not the most active
antibiotic agent of the defensin family, was found to become a very
potent agent when converted, through reduction of its disulﬁde
bridges, in an unstructured, ﬂexible random coil.
In the investigations illustrated above for T4 lysozyme [7],
chicken RNase A-2 [11], human RNase 3 [17,18], and hBD-1 [16],
it was also found that isolated synthetic peptides that reproduce
the sequences of stretches of the proteins’ amino acid sequences,
are as active as the entire (denatured or non-denatured) respective
proteins.
An elegant experiment of domain exchange, carried out with
peptide segments from chicken RNases A-1 and A-2, has revealed
that proteins closely related in their amino acid sequences do not
necessarily share the property of containing bactericidal peptides
[11].
Unpredictably, such isolated synthetic peptides were found to
be active also when their original amino acid sequence was
reversed [16], or randomized [11]. Recently, it has been reported
[19] that the antimicrobial activity of one of the RNases from zeb-
raﬁsh, ZF-RNase-3, depends on the presence in the protein
sequence of a peptide segment, which is liberated from the protein
by the action of a protease present on the bacterial membrane.
The latter ﬁndings may shed light on the question of denatured
proteins endowed with bactericidal activity, and may lead to test-
able hypotheses. It may be surmised that these proteins are not
bactericidal per se; rather, that they are bactericidal because they
store in their amino acid sequences peptide segments that display
bactericidal activity when cut out from the parent protein by the
action of membrane or cytosolic proteases.
These bactericidal proteins would thus be merely containers of
potential bactericidal peptides. Alternatively, it is also possible that
the embedded peptides are not excised from the proteins. They
could instead remain within the unfolded protein chain, and kill
bacteria because they could, in the presence of their bacterial tar-
gets, spontaneously assume 3D structures that enable them to bind
and/or penetrate the bacterial membrane.
A great attention has been given recently to antimicrobial pep-
tides, which contribute to the innate host defense against microbes
[20,21]. Thus, we can envision how besides producing fully struc-
tured anti-microbial proteins and peptides, evolution has also ledto the construction of pre-proteins with a hidden host defense
potential in their polypeptide structures.
In conclusion, the observations of denatured, but active bacteri-
cidal proteins suggest that structures, although buried in the pro-
tein amino acid sequences, may be needed for performing an
antimicrobial action. Incidentally, also these ﬁndings suggest that
a re-evaluation of the structure-to-function paradigm may not be
necessary.
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